Hongjun Yuan
Overview
Explore the profile of Hongjun Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
754
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma P, Kang S, Li H, Li M, Zhao Y, Yuan H, et al.
Sci Rep
. 2024 Dec;
14(1):32056.
PMID: 39738500
Triple-negative breast cancer (TNBC) seriously threatens women's health, and long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and play fundamental roles in TNBC. This study aimed...
2.
Guan D, Yuan H, Sun K, Zheng Y, Ju S, Xia W
Aesthetic Plast Surg
. 2024 Sep;
49(3):779-787.
PMID: 39317860
Background: Complications often arose after polyacrylamide hydrogel (PAAG) injections for breast augmentation. This study aimed to explore the complications and clinical management of breast augmentation with PAAG. Methods: We retrospectively...
3.
Lan Y, Yuan H, Ma X, Yin C, Liu X, Zeng X, et al.
CNS Neurosci Ther
. 2024 Aug;
30(8):e14915.
PMID: 39187974
Aims: To examine whether functional connectivity (FC) of the occipital gyrus differs between patients with Parkinson's disease (PD) motor subtypes and healthy controls (HCs). Methods: We enrolled 30 PD patients...
4.
Fang S, Xia W, Zhang H, Ni C, Wu J, Mo Q, et al.
Front Oncol
. 2024 Feb;
14:1323226.
PMID: 38420013
Purpose: This study aimed to develop and validate a clinicopathological model to predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients and identify key prognostic factors....
5.
Jia F, Sun S, Li J, Wang W, Huang H, Hu X, et al.
Cancer Lett
. 2024 Jan;
585:216656.
PMID: 38266804
Hormone receptor-positive breast cancer (HR BC) is known to be relatively insensitive to chemotherapy, and since chemotherapy has remained the major neoadjuvant therapy for HR BC, the undetermined mechanism of...
6.
Gul S, Pang J, Yuan H, Chen Y, Yu Q, Wang H, et al.
Sci Data
. 2023 Nov;
10(1):815.
PMID: 37985782
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and carries the worst prognosis, characterized by the lack of progesterone, estrogen, and HER2 gene expression. This study...
7.
Fang W, Fan T, Wang S, Yu X, Lu A, Wang X, et al.
Sci Total Environ
. 2023 Sep;
905:167027.
PMID: 37717779
Microbial communities play a vital role in urban river biogeochemical cycles. However, the seasonal variations in microbial community characteristics, particularly phylogenetic group-based community assembly and species coexistence, have not been...
8.
Xia W, Chen W, Ni C, Meng X, Wu J, Yang Q, et al.
Breast Cancer Res
. 2023 Jul;
25(1):85.
PMID: 37461019
Background: Chemoresistance involves metastasis and aggressiveness of breast cancer (BC). Chemotherapy-elicited exosomes have been reported to be associated with drug resistance and pro-metastatic capacity of BC cells. Non-coding RNAs (ncRNAs)...
9.
Qin Z, Liu H, Sheng Q, Dan J, Wu X, Li H, et al.
Eur J Immunol
. 2023 Jun;
53(9):e2250211.
PMID: 37377275
Type I interferons (IFN-Is) are a class of proinflammatory cytokines produced in response to viruses and environmental stimulations, resulting in chronic inflammation and even carcinogenesis. However, the connection between IFN-I...
10.
Yu K, Wei L, Yuan H, Zhang W, Zeng X, Wang B, et al.
Front Plant Sci
. 2022 Dec;
13:1076000.
PMID: 36561451
Qingke (Tibetan hulless barley, L. var. ) is the primary food crop on the Tibet Plateau, the long-term drought and other harsh environments makes qingke an important resource for the...